ClinicalTrials.gg
RecruitingNCT07348081RW-HOMECAREUpdated Jan 16, 2026

Real World Evidence to Assess the Value of a Digital Care Coordination and Monitoring Program for Supporting Caregivers of Adults Discharged From the Emergency Department.

An interventional study of Caregivers supporting vulnerable patients and using the MyMonka solution. in Frailty Syndrome and Caregiver Burden for Those Who Care for Adults With Impaired Functional Status, sponsored by Fondation Hôpital Saint-Joseph. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-01-16.

Sponsored by Fondation Hôpital Saint-Joseph · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 59 studies in Frailty with a site in France — 23 open to participants now, 25 under way, none of them phase 3. Frailty · France.

Planned enrollment
15th of 27
100 · median 106
Started
2025
with 9 others
No phase
27 of 59
9 open now
Primary completion
2027-03
later than 10 of 24 live
Registered
51st of 59
by date

Among the 59 studies in Frailty with a site in France, this one is the 15th largest by planned enrollment of the 27 interventional ones that give a count, is one of 10 that started in 2025, is one of 27 with no phase, reaches primary completion later than 10 of the 24 other live ones, and was the 51st registered.

Frailty

1,291 studies on the registry are indexed under Frailty; 454 are open to participants now.

Browse Frailty studies →

Open to participants now

23 of the 59 studies in Frailty with a site in France are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 299 Frailty studies recruiting now, 235 (79%) set no upper age limit and 10 (3%) stop at 75 or younger; 7 take children under 18; 66 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Frailty with a site in France, or all of them as a file.
02

Study summary

The RW-HOMECARE study is a prospective, longitudinal, real-world pilot trial designed to assess the impact of proposing the Monka digital solution to non-professional caregivers of patients discharged from emergency or short-stay units. The primary objective is to measure changes in caregiver burden using the ZBI-12 scale at baseline, 30 days, and 90 days. Secondary objectives include evaluating caregivers' physical and mental quality of life (SF-12), patient frailty (Clinical Frailty Scale), and the incidence of adverse events such as emergency visits, unplanned hospitalizations, falls, institutionalization, and death within 90 days. The study also examines the usability, acceptability, and satisfaction with Monka digital solution through standardized questionnaires, the correlation between algorithm-generated vulnerability scores and established measures, and reasons for non-adoption.

Eligible dyads (patient and caregiver) are recruited at discharge from emergency or short-stay units. After informed consent, caregivers receive free access to Monka digital solution for 3 months, along with a user guide. Follow-up assessments are conducted by phone at Day 30 and Day 90 (±14 days). All interventions by the coordinating nurse are tracked and analyzed quantitatively and qualitatively.

03

Conditions studied

  • Frailty Syndrome
  • Caregiver Burden for Those Who Care for Adults With Impaired Functional Status

Browse trials for

Keywords

  • Frailty syndrome
  • Non-professional caregiver
  • Burden
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

FOR THE PATIENT

  • Person aged 18 or over, treated in the Emergency Department or Emergency Beds
  • Affiliated with Social Security
  • Having an adult non-professional relative helping them with one or more activities of daily living
  • Having a medical decision to return home within the next 72 hours
  • Who has given their free, informed, and express consent FOR THE CAREGIVER
  • Individuals aged 18 or older
  • Who are non-professional caregivers as defined in Article L. 113-1-3 of the Social Action and Families Code, living with or separately from the person being cared for (20)
  • Providing assistance to the patient with one or more activities of daily living, i.e., shopping, medical appointments, coordination of care, administrative tasks, and moral support
  • Access to a cell phone, computer, or tablet with an internet connection
  • Having given their free, informed, and express consent

Exclusion criteria

Exclusion Criteria:

FOR THE PATIENT

  • Non-French speakers
  • People living in a medical institution or scheduled for institutionalization within the next 3 months
  • People receiving home hospitalization (HAD) or palliative care at home
  • People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle) FOR THE CAREGIVER
  • Non-French speakers
  • People with cognitive or psychiatric disorders that prevent them from understanding and using the MONKA solution
  • People under legal protection, deprived of their liberty, or under legal guardianship (tutelage or curatelle)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Patient and caregiver dyad experiencing the MyMonka solution in real-life conditions

    Other: Caregivers supporting vulnerable patients and using the MyMonka solution.

Interventions

  • OtherCaregivers supporting vulnerable patients and using the MyMonka solution.

    Testing of the MyMonka solution; Response to questionnaires during the follow-up period on quality of life and burden measurement

06

What researchers measure

Primary outcomes

  1. Change in the score on the 12-item Zarit Burden Interview questionnaire (ZBI-12, Appendix 1), measured on days 0, 30, and 90, among family caregivers participating in the study.

    Time frame: Days 0, 30 and 90

Secondary outcomes

  1. Change in the physical and mental quality of life of caregivers, expressed as the difference between SF-12 questionnaire scores at baseline, on day 30, and on day 90.

    Time frame: Days 30 and 90

  2. Change in patient frailty expressed as the difference between the Clinical Frailty Scale score obtained at inclusion and on day 90.

    Time frame: Days 0 and 90

  3. Percentage of people affected by the following adverse events within three months of returning home: new emergency room visits, unscheduled hospitalizations and their duration, falls, home hospitalizations, institutionalization, and death.

    Time frame: Days 90

  4. Evaluation of the use, acceptability, usability, and impact of the Monka digital solution for caregivers through intervention tracking, algorithm-based vulnerability assessment, and standardized questionnaires over a 90-day period.

    Time frame: Days 0 and 90

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Mar 2027, 15 months after the start.

Of 514 non-industry interventional studies with no phase under Frailty, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 39. This study's planned 15 months is below that.

Counting every sponsor, half of 519 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 11, 2025
First posted
Jan 16, 2026
StartActual
Dec 12, 2025
Primary completionEst.
Mar 12, 2027
CompletionEst.
Mar 12, 2027
Last update
Jan 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07348081
Collaborators
Monka Care
Responsible party
Sponsor
First posted
Jan 16, 2026
Start date
Dec 12, 2025
Primary completion
Mar 12, 2027 (estimated)
Completion
Mar 12, 2027 (estimated)
Last update
Jan 16, 2026

Study contacts

Camilla GERLIER, Doctor
Contact
cgerlier@ghpsj.fr
01·44·12·80·23
Célia MAMMA
Contact
cmamma@ghpsj.fr
01·44·12·32·54

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion